A small intestinal bile acid modulates the gut microbiome to improve host metabolic phenotypes following bariatric surgery

• DOI: 10.1016/j.chom.2024.06.014
• Publication Date: 2024-07-22T14:40:04Z
• Authors: Yingjia Chen; Snehal N. Chaudhari; David A. Harris; Cullen F. Roberts; Andrei Moscalu; Vasundhara Mathur; Lei Zhao; Ali Tavakkoli; A. Sloan Devlin; Eric G. Sheu
• Keywords: Bile Acids and Salts; Mice, Inbred C57BL; Male; Mice; Glucose; Diabetes Mellitus, Type 2; Intestine, Small; Animals; Bariatric Surgery; Humans; Lithocholic Acid; Obesity; Gastrointestinal Microbiome

Bariatric surgical procedures such as sleeve gastrectomy (SG) provide effective type 2 diabetes (T2D) remission in human patients. Previous work demonstrated that gastrointestinal levels of the bacterial metabolite lithocholic acid (LCA) are decreased after SG in mice and humans. Here, we show that LCA worsens glucose tolerance and impairs whole-body metabolism. We also show that taurodeoxycholic acid (TDCA), which is the only bile acid whose concentration increases in the murine small intestine post-SG, suppresses the bacterial bile acid-inducible (bai) operon and production of LCA both in vitro and in vivo. Treatment of diet-induced obese mice with TDCA reduces LCA levels and leads to microbiome-dependent improvements in glucose handling. Moreover, TDCA abundance is decreased in small intestinal tissue from T2D patients. This work reveals that TDCA is an endogenous inhibitor of LCA production and suggests that TDCA may contribute to the glucoregulatory effects of bariatric surgery.